TOKYO (Reuters) – Japan’s Kobayashi Pharmaceutical said on Friday it was investigating 76 deaths and their potential relationship with its dietary supplements containing “Beni-Koji” red yeast.
The company previously reported five deaths possibly linked to the product.
(Reporting by Kantaro Komiya; Editing by Christopher Cushing)
Comments